This is the third installment in the series on changes coming to the Clinical Research enterprise that John Neal began in April 2016, with the prediction that “major changes are coming that will be disruptive, displacing many people currently working in the industry.”
John’s second prediction was that “there will be a decrease in the number of single drug studies in the future.” He first presented these predictions, and the others that will follow, at the ACRP 2016 Meeting & Expo in Atlanta in April 2016 in a presentation on the “Future of Clinical Research” during the ACRP Executive Summit on Site Strategies.
For background information as to what is driving the changes John predicts are coming, please see the first article in this series titled “Change is in the air.”
Based on his research, John made eighteen primary predictions at the Summit. Because he based each prediction on numerous interviews, significant background data, and other relevant information, we are presenting them in a series, with one or more predictions, and the relevant support, presented each week in the ACRP Community Online Forum. Each week John will make another post here, with the details posted in the ACRP Online Community Open Forum at http://community.acrpnet.org/home. The ACRP Online Forum is available to all ACRP Members in good standing.
John’s third prediction is made up of two parts, which are . . .
The process by which Sites are selected to conduct studies will be radically transformed, and fewer sites will be needed in the future
Visit the ACRP Online Community Open Forum at http://community.acrpnet.org/home to read the details behind these and John’s previous predictions in this series.
Copyright © 2016, PCRS Network, LLC. ALL RIGHTS RESERVED.
